LogoLogo
  • About Us
    • About Aurobindo
    • Vision / Mission
    • Milestones
    • R&D
    • Manufacturing
    • Management
      • Board of Directors
    • Our Presence
  • Our Business
    • APUSA
    • Europe
    • Growth Markets
    • ARV
      • Overview
      • Key facts about HIV/AIDS
      • Products
      • Global Partners
      • Gallery
      • Corporate Video
    • Apitoria (API)
    • Eugia (Speciality products)
    • Curateq (Biosimilars) / Peptide
  • Sustainability
    • ESG / Sustainability
      • ESG Profile
      • Sustainability Reports
      • BMW Reports
    • Social Accountability Standards
      • Social Compliance Certification
      • Sustainability of Social Accountability Standards
      • Human Rights Policy
      • Progressive Health and Safety Practices
      • Community Impact
      • Supply Chain Management
      • Supplier Code of Conduct
    • CSR
      • Aurobindo Pharma Foundation
      • CSR Policy
      • Annual Report
      • Gallery
      • Annual Action Plan
      • Impact Assessment Reports - CSR Projects
    • Access to Healthcare
      • PEPFAR program
  • Investors
    • Results, Reports & Presentations
      • Results Announcements
      • Annual Reports
      • Financials - Subsidiaries
      • Related Party Transactions
    • Shareholder Information
      • Shareholding Pattern
      • Buyback of shares
      • Share Performance
      • Financial Highlights
      • Notice of Board Meetings
      • General Meetings
      • Dividend Record
      • Scheme of Arrangements
      • Unpaid Dividend Account Details
      • Registrar and Share Transfer Agent
      • Contact Details for Investor Grievance Redressal
      • Special window for lodgement of physical shares
    • Corporate Governance
      • Board of Directors
      • Governance Policies
      • Code of Conduct
      • Code of Practices and Procedures for Fair Disclosure
      • Appointment and Resignation of Directors
      • Contact Details of KMPs
      • IR Contacts
    • Disclosures Under Regulation 46
      • Disclosures under Regulation 46 of the LODR
  • Media
    • Press Releases
    • Corporate Kit
  • Careers
    • Our Culture & Values
    • Life @ Aurobindo
    • Work with us / Opportunities
  • Contact Us

Investors

Commitment towards creating consistent value for our shareholders

Schedule of Meeting

2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

24.09.2026

PDF icon

22.09.2026

PDF icon

21.09.2026

PDF icon

17.09.2026 (2)

PDF icon

18.09.2026

PDF icon

17.09.2026

PDF icon

01.09.2026

PDF icon

September 1-2, 2026

PDF icon

19.08.2026

PDF icon

11.08.2026 to 13.08.2026

PDF icon

12.06.2026

PDF icon

10.06.2026

PDF icon

08.06.2026

PDF icon

04.06.2026

PDF icon

02.06.2026

PDF icon

29.05.2026

PDF icon

17.03.2026

PDF icon

16.03.2026

PDF icon

13.03.2026

PDF icon

06.03.2026

PDF icon

12.02.2026

PDF icon

11.02.2026

PDF icon

13.01.2026

PDF icon

Earnings Call Details

2026 - 27
2025 - 26
2024 - 25
2023 - 24
2022 - 23
2021 - 22
2020 - 21
2019 - 20
2018 - 19
2017 - 18
2016 - 17

Q1FY2027

PDF icon
Footer Logo

REGISTERED OFFICE

Plot no. 2, Maitrivihar, Ameerpet, Hyderabad-500038, Telangana, India.

CORPORATE OFFICE

Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City,
Raidurg Panmaktha, Rangareddy District,
Hyderabad - 500032, Telangana, India.

  • About Us
  • Our Business
  • Sustainability
  • Investors
  • Media
  • Careers
  • Contact Us
  • Privacy Policy
  • Site Map

© 2026 Aurobindo Pharma Limited. All rights reserved.